Renaissance Technologies LLC Sells 886,427 Shares of Oscar Health, Inc. (NYSE:OSCR)

Renaissance Technologies LLC reduced its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 24.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,677,673 shares of the company's stock after selling 886,427 shares during the quarter. Renaissance Technologies LLC owned 1.08% of Oscar Health worth $35,988,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of OSCR. State Street Corp increased its stake in shares of Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock valued at $108,867,000 after buying an additional 291,335 shares during the period. Lingotto Investment Management LLP acquired a new position in Oscar Health in the 4th quarter valued at approximately $2,543,000. GDS Wealth Management raised its stake in shares of Oscar Health by 1,545.3% during the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company's stock valued at $4,648,000 after acquiring an additional 324,798 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Oscar Health by 296.0% in the fourth quarter. Victory Capital Management Inc. now owns 231,059 shares of the company's stock valued at $3,105,000 after purchasing an additional 172,706 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Oscar Health during the fourth quarter worth about $5,672,000. Institutional investors own 75.70% of the company's stock.

Oscar Health Price Performance

Shares of NYSE:OSCR traded up $0.05 on Tuesday, hitting $12.47. The company's stock had a trading volume of 2,432,006 shares, compared to its average volume of 3,865,227. Oscar Health, Inc. has a 1 year low of $11.47 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market capitalization of $3.12 billion, a PE ratio of -622.94 and a beta of 1.75. The company has a 50-day simple moving average of $13.95 and a 200 day simple moving average of $15.26.

Remove Ads

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Sell-side analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, Oscar Health presently has a consensus rating of "Hold" and an average target price of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.